Stock listing
NASDAQ:BLUE Bluebird bio Inc Stock
Follow Bluebird bio Inc into a list and get an email when it puts out news.
Last close · NASDAQ:BLUE
$4.97 USD
Close on May 30, 2025 · No longer trades
- Lowest – highest close
- $3.29 – $9.92 USDSince Dec 13, 2024 · lowest May 12, 2025 · highest Jan 6, 2025
Delisted NASDAQ:BLUE no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:BLUE
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
Bluebird bio Inc on 6ix
- Calls
- 9 calls with a replay · 9 with a transcript · latest Nov 14, 2024
- Decks
- 27 decks · latest Jan 8, 2024
Events
| Call | When | Status |
|---|---|---|
| Bluebird bio (BLUE) Q3 2024 Earnings Call | Thu, Nov 14, 2024 · 8:00 AM ET | Replay |
| Bluebird bio (BLUE) Q2 2024 Earnings Call | Wed, Aug 14, 2024 · 8:00 AM ET | Replay |
| Bluebird bio (BLUE) Q1 2024 Earnings Call | Thu, May 09, 2024 · 8:00 AM ET | Replay |
| Bluebird bio (BLUE) Q4 2023 Earnings Call | Tue, Mar 26, 2024 · 8:00 AM ET | Replay |
| Bluebird bio (BLUE) Q3 2023 Earnings Call | Tue, Nov 07, 2023 · 8:00 AM ET | Replay |
| Bluebird bio (BLUE) Q2 2023 Earnings Call | Tue, Aug 08, 2023 · 8:00 AM ET | Replay |
| Bluebird bio (BLUE) Q4 2022 Earnings Call | Wed, Mar 29, 2023 · 8:00 AM ET | Replay |
| Bluebird bio (BLUE) Q1 2022 Earnings Call | Tue, Apr 05, 2022 · 8:00 AM ET | Replay |
| Bluebird bio (BLUE) Q2 2021 Earnings Call | Mon, Aug 09, 2021 · 8:00 AM ET | Replay |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| J.P. Morgan Healthcare Conference 2024 | Conference | 23 slides | Jan 8, 2024 |
| Corporate Update (December 2023) | Corporate update | 17 slides | Dec 11, 2023 |
| Q2 2023 Earnings Presentation | Earnings | 16 slides | Aug 8, 2023 |
| Investor Presentation (July 2023) | Investor deck | 27 slides | Jul 12, 2023 |
| Investor Presentation (June 2023) | Investor deck | 27 slides | Jun 12, 2023 |
| J.P. Morgan Healthcare Conference 2023 | Conference | 29 slides | Jan 9, 2023 |
| Conference Presentation (January 2021) | Conference | 27 slides | Jan 11, 2021 |
| ASH 2019 | Conference | 38 slides | Dec 10, 2019 |
| EHA Data Review & ZYNTEGLO Approval Webcast (June 2019) | Conference | 38 slides | Jun 14, 2019 |
| 39th Annual Cowen Healthcare Conference 2019 | Conference | 10 slides | Mar 12, 2019 |
All 27 decks
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Michael Cloonan Other companies: Sionna Therapeutics, Inc. (President & CEO, Director · Since at least Feb 6, 2025); Sage Therapeutics Inc (Chief Business Officer · Apr 2, 2018 – Feb 10, 2021 · Past) | Director · Since at least Jun 20, 2024 |
| Nick Leschly Other companies: 2Seventy Bio Inc (Director · Oct 18, 2021 – May 13, 2025 · Past); Synlogic Inc (Director · Jun 10, 2021 – Jun 22, 2023 · Past) | Director · Since at least Oct 2, 2020 |
| Jeffrey T. Walsh Other companies: Tenaya Therapeutics, Inc. (Board Member · Since at least Jul 29, 2021) | Chief Strategy Officer · Mar 11, 2019 – Aug 20, 2019 · Past |
| Joseph Vittiglio Other companies: PepGen Inc. (Chief Business & Legal Officer · Since at least Dec 8, 2025) | Chief Business & Legal Officer · Since at least May 30, 2025 |
| Kory Wentworth Other companies: Entrada Therapeutics, Inc. (Chief Financial Officer · Since at least Oct 28, 2021) | Principal Accounting Officer · Dec 18, 2017 – Aug 3, 2020 · Past |
| O James Sterling Other companies: Renalytix PLC (Chief Financial Officer · Jul 1, 2023 – Jul 6, 2023 · Past) | Chief Financial Officer · Since at least Jun 10, 2024 |
| Richard Paulson Other companies: Karyopharm Therapeutics Inc. (President and CEO, Director · Since at least Apr 4, 2025) | Director · Since at least May 30, 2025 |
| William R Sellers Other companies: 2Seventy Bio Inc (Director · Oct 18, 2021 – Nov 11, 2021 · Past) | Director · Sep 25, 2019 – Nov 11, 2021 · Past |
| Andrew Obenshain | President and CEO, Director · Since at least Nov 3, 2023 |
| Douglas Melton | Director · Jun 6, 2019 – Jun 18, 2020 · Past |
All 14 people
| Person | Seat |
|---|---|
| Jessica Whitten | Chief Accounting Officer · Nov 4, 2021 – Feb 1, 2022 · Past |
| Mark Vachon | Director · Since at least Nov 6, 2024 |
| Najoh Tita-Reid | Director · Since at least Jun 22, 2022 |
| Richard A Colvin | Chief Medical Officer · Since at least May 30, 2025 |
Log in to ask 6ix AI your own questions about Bluebird bio Inc.